{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:08:10Z","timestamp":1792382890643,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/ki.2014.372","type":"journal-article","created":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T16:36:46Z","timestamp":1418229406000},"page":"1039-1045","source":"Crossref","is-referenced-by-count":67,"title":["Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease"],"prefix":"10.1016","volume":"87","author":[{"given":"Rodrigo A.","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fellype C.","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciene M.","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Henrique","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zita Maria L.","family":"Britto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor D.B.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aluizio B.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Moys\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"Jorgetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2014.372_bb0010","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/ajkd.2000.19093","article-title":"Parathormone secretion in peritoneal dialysis patients with adynamic bone disease","volume":"36","author":"Carmen S\u00e1nchez","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.372_bb0015","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ki.1994.340","article-title":"Osteocalcin: a non-invasive index of metabolic bone disease in patients treated by CAPD","volume":"46","author":"Joffe","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.372_bb0020","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2014an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.372_bb0025","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.372_bb0030","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2014.372_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/089686089701700113","article-title":"Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover","volume":"17","author":"Kurz","year":"1997","journal-title":"Perit Dial Int"},{"key":"10.1038\/ki.2014.372_bb0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bone.2003.05.002","article-title":"Misconceptions (3): calcium leaves bone only by resorption and enters only by formation","volume":"33","author":"Parfitt","year":"2003","journal-title":"Bone"},{"key":"10.1038\/ki.2014.372_bb0045","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","article-title":"K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients","volume":"73","author":"Barreto","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.372_bb0050","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/ndt\/gft275","article-title":"Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts","volume":"29","author":"Delanaye","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.372_bb0055","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/ajkd.2002.34535","article-title":"Biochemical measurements in the prediction of histologic subtype of renal transplant bone disease in women","volume":"40","author":"Parker","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.372_bb0060","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Ure\u00f1a","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.372_bb0065","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.372_bb0070","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ndt\/gfr270","article-title":"Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients","volume":"27","author":"Cejka","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.372_bb0075","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.V1351307","article-title":"Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial","volume":"13","author":"Paniagua","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"4 Suppl 3","key":"10.1038\/ki.2014.372_bb0080","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.372_bb0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/089686080602600107","article-title":"Adynamic bone revisited: is there progress?","volume":"26","author":"Sanchez","year":"2006","journal-title":"Perit Dial Int"},{"key":"10.1038\/ki.2014.372_bb0090","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.372_bb0095","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.ki.5001666","article-title":"Reversal of adynamic bone disease by lowering of dialysate calcium","volume":"70","author":"Haris","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.372_bb0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bone.2006.09.011","article-title":"Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways","volume":"40","author":"Alikhani","year":"2007","journal-title":"Bone"},{"key":"10.1038\/ki.2014.372_bb0105","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jcb.20875","article-title":"Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization","volume":"99","author":"Van Driel","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1038\/ki.2014.372_bb0110","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2011-2958","article-title":"Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes","volume":"97","author":"Gennari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2014.372_bb0115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/sj.ki.5002084","article-title":"Decreased in vitro osteoblast proliferation and low turnover bone disease in nonuremic proteinuric patients","volume":"71","author":"Dias","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.372_bb0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jsbmb.2012.09.009","article-title":"Vitamin D metabolism and action in human marrow stromal cells: effects of chronic kidney disease","volume":"136","author":"Zhou","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1038\/ki.2014.372_bb0125","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/\u03b2-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2014.372_bb0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000245640","article-title":"Phosphate elimination in modalities of hemodialysis and peritoneal dialysis","volume":"29","author":"Kuhlmann","year":"2010","journal-title":"Blood Purif"},{"key":"10.1038\/ki.2014.372_bb0135","doi-asserted-by":"crossref","first-page":"79721","DOI":"10.1371\/journal.pone.0079721","article-title":"Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease\u2014role of sclerostin?","volume":"8","author":"Ferreira","year":"2013","journal-title":"PloS One"},{"key":"10.1038\/ki.2014.372_bb0140","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s11255-009-9561-x","article-title":"Loss via peritoneal fluid as a factor for low 25(OH)D3 level in peritoneal dialysis patients","volume":"41","author":"Sahin","year":"2009","journal-title":"Int Urol Nephrol"},{"key":"10.1038\/ki.2014.372_bb0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.jrn.2010.03.005","article-title":"Vitamin D deficiency in dialysis patients: effect of dialysis modality and implications on outcome","volume":"20","author":"Gracia-Iguacel","year":"2010","journal-title":"J Ren Nutr"},{"key":"10.1038\/ki.2014.372_bb0150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3747\/pdi.2009.00108","article-title":"Risk factors for peritoneal dialysis-associated peritonitis: the role of oral active vitamin d","volume":"30","author":"Rudnicki","year":"2010","journal-title":"Perit Dial Int"},{"key":"10.1038\/ki.2014.372_bb0155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11255-010-9813-9","article-title":"Hypovitaminosis D and insulin resistance in peritoneal dialysis patients","volume":"43","author":"Bindal","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"10.1038\/ki.2014.372_bb0160","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/ndt\/gfn584","article-title":"A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients","volume":"24","author":"Adrag\u00e3o","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.372_bb0165","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2013-2786","article-title":"Renal elimination of sclerostin increases with declining kidney function","volume":"99","author":"Cejka","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2014.372_bb0170","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0272-6386(03)00197-5","article-title":"Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients","volume":"41","author":"Bervoets","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.372_bb0175","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ki.2012.166","article-title":"Bone microarchitecture is more severely affected in patients on hemodialysis than in those receiving peritoneal dialysis","volume":"82","author":"Pelletier","year":"2012","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"10.1038\/ki.2014.372_bb0180","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.2215\/CJN.00460107","article-title":"Technical approach to iliac crest biopsy","volume":"3","author":"Hernandez","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.372_bb0185","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2014.372_bb0190","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00774-007-0778-4","article-title":"Brazilian normal static bone histomorphometry: effects of age, sex, and race","volume":"25","author":"Dos Reis","year":"2007","journal-title":"J Bone Miner Metab"},{"key":"10.1038\/ki.2014.372_bb0195","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0221-8747(83)90004-8","article-title":"Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects","volume":"5","author":"Vedi","year":"1983","journal-title":"Metab Bone Dis Relat Res"},{"key":"10.1038\/ki.2014.372_bb0200","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jcp.37.2.136","article-title":"Detection and distribution of aluminium in bone","volume":"37","author":"Denton","year":"1985","journal-title":"J Clin Pathol"},{"key":"10.1038\/ki.2014.372_bb0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00774-007-0788-2","article-title":"Usefulness of a quick decalcification of bone sections embedded in methyl methacrylate: an improved method for immunohistochemistry","volume":"26","author":"Gomes","year":"2008","journal-title":"J Bone Miner Metab"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815300922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815300922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T04:58:32Z","timestamp":1650776312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815300922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0085253815300922"],"URL":"https:\/\/doi.org\/10.1038\/ki.2014.372","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}